English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Nov 19, 2025

Precautions advised by allergists for managing holiday allergy and asthma triggers

Patient Daily | Nov 19, 2025

Dauten family donates $25 million for new Northwestern Medicine Behavioral Health Institute

Patient Daily | Nov 18, 2025

Pacific Research Institute CEO: 340B misuse is 'reducing competition, narrowing patient choices, and driving costs up'

Patient Daily | Nov 18, 2025

Tips from Baylor psychiatrist on handling political talk during holidays

Patient Daily | Nov 17, 2025

Baylor College of Medicine doctors warn about risks of air pollution on lung health

Patient Daily | Nov 17, 2025

Baylor receives $10 million NIH grant for precision models in rare disease research

Patient Daily | Nov 17, 2025

UTHealth Houston researchers develop AI app for thoracic aortic disease assessment

Patient Daily | Nov 14, 2025

UTHealth Houston explores virtual reality gaming as rehabilitation tool for stroke survivors

Trending

+ Regulatory
Patient Daily | Apr 28, 2026

Archo Advocacy CEO Toresco on PBMs: 'PBMs profit from keeping prices high. Patients pay the spread'

+ Pharmaceuticals
Patient Daily | Apr 24, 2026

Washington Post Opinion Editor on 340B drug discounts: 'The program has become a profit-making venture for big businesses'

+ Regulatory
Patient Daily | Apr 29, 2026

USC Schaeffer Center's Sood on PBMs: 'If PBMs want to claim they save employers and patients billions, they should be willing to prove it'

+ Regulatory
Patient Daily | Apr 24, 2026

Steve Forbes on 340B program: Hospitals use it ‘to divert taxpayer-subsidized benefits for patients to unrelated interests’

  • « First
  • «
  • …
  • 139
  • 140
  • 141
  • 142


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily